Marjolaine Gauthier-Loiselle

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Attention Deficit Hyperactivity Disorder

Cardiovascular Events

Health Insurance

Ejection Fraction

Top Venues

Journal of comparative effectiveness research

Journal of medical economics

Patient preference and adherence

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Yan Meng, Beatrice Libchaber, Fanny Jiang, Ann Childress
Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder - A Discrete Choice Experiment. Patient preference and adherence 18 (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Jeff Schein, Martin Cloutier, Rebecca L Bungay, Marjolaine Gauthier-Loiselle, Ann C Childress
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of medical economics 27 (1) (2024)
Jeff Schein, Martin Cloutier, Rebecca L Bungay, Marjolaine Gauthier-Loiselle, Ann C Childress
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of medical economics 27 (1) (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Yan Meng, Beatrice Libchaber, Fanny Jiang, Ann Childress
Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder - A Discrete Choice Experiment. Patient preference and adherence 18 (2024)
Jeff Schein, Martin Cloutier, Rebecca L Bungay, Marjolaine Gauthier-Loiselle, Ann C Childress
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of medical economics (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Therese Sargent, Yuen Tsang, Sumeet Panjabi, Vienica Funtanilla, Hayley D Germack, Marjolaine Gauthier-Loiselle, Ameur M Manceur, Martin Cloutier, Patrick Lefebvre
Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis. Advances in therapy (2023)
Yuen Tsang, Sumeet Panjabi, Vienica Funtanilla, Hayley D Germack, Marjolaine Gauthier-Loiselle, Ameur M Manceur, Stephanie Liu, Martin Cloutier, Patrick Lefebvre
Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD). Pulmonary circulation 13 (2) (2023)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin, Ann Childress
Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study. Advances in therapy 39 (12) (2022)
Martin Cloutier, Ameur M Manceur, Annie Guerin, Myrlene Sanon Aigbogun, Dorothee Oberdhan, Marjolaine Gauthier-Loiselle
The societal economic burden of autosomal dominant polycystic kidney disease in the United States. BMC health services research 20 (1) (2020)
James B Young, Marjolaine Gauthier-Loiselle, Robert A Bailey, Ameur M Manceur, Patrick Lefebvre, Morris Greenberg, Marie-Hélène Lafeuille, Mei Sheng Duh, Brahim Bookhart, Carol H Wysham
Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data. Cardiovascular diabetology 17 (1) (2018)